Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-073412
Filing Date
2024-06-14
Accepted
2024-06-14 11:00:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 engene-424b3_june_2024.htm 424B3 1553565
2 GRAPHIC img22310934_0.jpg GRAPHIC 14394
  Complete submission text file 0000950170-24-073412.txt   1574561
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 424B3 | Act: 33 | File No.: 333-275700 | Film No.: 241043516
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)